Guiqiu Hu Selected Research

farrerol

1/2020	Corrigendum to 'Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways'. [Int. Immunopharmacol. 75 (2019) 105739].
10/2019	Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
7/2018	Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guiqiu Hu Research Topics

Disease

8	Inflammation (Inflammations) 02/2022 - 07/2018
7	Neuroinflammatory Diseases 07/2022 - 01/2019
5	Mastitis 02/2022 - 01/2019
4	Parkinson Disease (Parkinson's Disease) 01/2021 - 10/2019
2	Weight Loss (Weight Reduction) 07/2022 - 01/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 11/2022
1	Movement Disorders (Movement Disorder) 07/2022
1	Infections 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Herpes Zoster 01/2019
1	Colitis 07/2018

Drug/Important Bio-Agent (IBA)

8	LipopolysaccharidesIBA 02/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 02/2022 - 01/2020
3	farrerolIBA 01/2020 - 07/2018
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2019
2	Neuroprotective AgentsIBA 07/2022 - 01/2021
2	AntioxidantsIBA 07/2022 - 01/2020
2	evodiamineIBA 02/2022 - 01/2021
2	Claudin-3IBA 12/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2019
2	OccludinIBA 12/2021 - 01/2019
2	Tight Junction ProteinsIBA 12/2021 - 01/2019
2	isovitexinIBA 01/2020 - 01/2019
1	Cyclin D1IBA 11/2022
1	Arginine (L-Arginine)FDA Link 11/2022
1	Carrier Proteins (Binding Protein)IBA 11/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2022
1	Eukaryotic Initiation Factor-4EIBA 11/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2022
1	E2F1 Transcription FactorIBA 11/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 11/2022
1	TOR Serine-Threonine KinasesIBA 11/2022
1	hordenineIBA 07/2022
1	Oxidopamine (6 Hydroxydopamine)IBA 07/2022
1	CytokinesIBA 02/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	FlavonoidsIBA 12/2021
1	pedunculosideIBA 12/2021
1	echinocystic acidIBA 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	beta-NaphthoflavoneIBA 01/2020
1	dehydroandrographolideIBA 01/2020
1	SteroidsIBA 01/2020
1	dioscinIBA 01/2020
1	InflammasomesIBA 01/2020
1	SaponinsIBA 01/2020
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	vanillinIBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	InterleukinsIBA 01/2019
1	Sulfonic AcidsIBA 07/2018
1	sym-trinitrobenzeneIBA 07/2018

Therapy/Procedure

1	Therapeutics 01/2020